Pharma Two B, an Israeli company which develops fixed-dose combination drugs, has announced that it has raised $8 million in its second financing round. The company says that it will use the funds to continue the development of its early-stage Parkinson’s disease treatment.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments